Compare
Stark Focus Group, Inc. vs Weyco Group Inc vs Authentic Holdings, Inc. vs VitaNova Life Sciences Corp
| Latest fiscal year | Stark Focus Group, Inc. SKFG | Weyco Group Inc WEYS | Authentic Holdings, Inc. AHROLast annual report: year ended 2024-12-31 | VitaNova Life Sciences Corp VNOV |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2024-12-31 | 2026-04-30 |
| Revenue | n/a | $276.17M | $398.6K | $3.03M |
| Revenue growth (YoY) | n/a | -4.9% | n/a | +13.7% |
| Gross margin | n/a | 43.2% | 68.1% | 30.1% |
| Operating margin | n/a | 10.6% | -182.1% | 0.1% |
| Net margin | n/a | 8.4% | -331.2% | -1.2% |
| Net income | -$42.1K | $23.08M | -$1.32M | -$37.3K |
| EPS (Diluted) | $0.00 | $2.41 | $0.00 | n/a |
| Operating cash flow | -$27.1K | $37.25M | -$126.7K | $814.4K |
| Free cash flow | n/a | $35.50M | n/a | n/a |
| Cash & equivalents | n/a | $96.01M | n/a | n/a |
| Total assets | $0 | $319.67M | $4.49M | $2.45M |
| Total liabilities | $182.8K | $80.10M | $5.53M | $395.8K |
| Shareholders' equity | -$182.8K | $239.57M | -$1.04M | $2.05M |
| Return on year-end equity | n/a | 9.6% | n/a | -1.8% |
| Shares outstanding | 9.95M | 9.53M | 2.26B | 8.34M |
Revenue, most recent five fiscal years
| Fiscal year | Stark Focus Group, Inc. | Weyco Group Inc | Authentic Holdings, Inc. | VitaNova Life Sciences Corp |
|---|---|---|---|---|
| Latest | $44.3K Ended 2020-12-31 | $276.17M Ended 2025-12-31 | $398.6K Ended 2024-12-31 | $3.03M Ended 2026-04-30 |
| 1 year earlier | $26.1K Ended 2019-12-31 | $290.29M Ended 2024-12-31 | $0 Ended 2023-12-31 | $2.66M Ended 2025-04-30 |
| 2 years earlier | n/a | $318.05M Ended 2023-12-31 | $0 Ended 2022-12-31 | $570.7K Ended 2024-04-30 |
| 3 years earlier | n/a | $351.74M Ended 2022-12-31 | $5.9K Ended 2021-12-31 | $38.0K Ended 2023-04-30 |
| 4 years earlier | n/a | $267.64M Ended 2021-12-31 | $4.0K Ended 2020-12-31 | $120.0K Ended 2022-04-30 |